News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/January-2018/Dubsky_Peter_Lucerne_web.jpg)
EndoPredict results reflected tumor response to neoadjuvant therapy
- Author:
- Susan London
SAN ANTONIO – The results of the EndoPredict test appear to predict tumor response in patients with early hormone receptor–positive, HER2-negative...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/December-2017/Warnberg_Fredrik_SWEDEN_web.jpg)
DCIS risk signature is validated in SweDCIS population
- Author:
- Susan London
SAN ANTONIO – The biologic risk signature was not only prognostic, but also predictive for radiotherapy benefit.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/December-2017/129691_Chlebowski_Rowan_T_web.jpg)
Postmenopausal women who shed pounds see lower breast cancer risk
- Author:
- Susan London
SAN ANTONIO – Compared with peers who had stable weight, women who lost at least 5% of their body weight had a lower risk of invasive breast...
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
PANACEA: pembrolizumab overcomes trastuzumab resistance for some
- Author:
- Susan London
SAN ANTONIO – Pembrolizumab overcomes trastuzumab resistance in some HER2-positive advanced breast cancer if the tumor expresses PD-L1.
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Ovarian suppression during breast cancer chemo helps stave off early menopause, preserve fertility
- Author:
- Susan London
SAN ANTONIO
News
![Dr. Rowan Chlebowski in a video interview.](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/December-2017/screenshot_84.jpg)
VIDEO: Weight loss cut risk of breast cancer
- Author:
- Susan London
SAN ANTONIO – Women in the Women’s Health Initiative Observational Study who lost at least 5% of their body weight had a significant 12% reduction...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/December-2017/Gray_Richard_ENGLAND_web.jpg)
Dose intensification gets more mileage out of adjuvant chemo
- Author:
- Susan London
SAN ANTONIO – Women were less likely to experience recurrence or die of breast cancer if they were given dose-intensified chemotherapy.
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/December-2017/screenshot_81.jpg)
VIDEO: Dr. Matteo Lambertini answers questions on temporary ovarian suppression
- Author:
- Susan London
SAN ANTONIO – Temporarily suppressing ovarian function with a gonadotropin-releasing hormone analog during chemotherapy helps preserve fertility...
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/December-2017/sabcs.jpg)
VIDEO: Dr. Sherene Loi discusses PANACEA trial and implications for pembrolizumab use
- Author:
- Susan London
SAN ANTONIO – The ORR was 15.2% in the phase 1b/2 PANACEA trial of pembrolizumab and trastuzumab in trastuzumab-resistant HER2+ advanced breast...
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/December-2017/sabcs2.jpg)
VIDEO: Meta-analysis lead author Dr. Richard Gray on dose intensity benefit
- Author:
- Susan London
SAN ANTONIO – Increasing the dose intensity of adjuvant chemotherapy reduced risks of breast cancer recurrence and death by about 15% in an EBCTCG...
News
Levofloxacin prophylaxis in AML reduces febrile neutropenia admissions
- Author:
- Susan London
The results support recommendations made by the Infectious Diseases Society of America and the National Comprehensive Cancer Network.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/November-2017/Angell_Trevor_E_web.jpg)
Cancer patients with TKI-induced hypothyroidism had better survival rates
- Author:
- Susan London
When it comes to the adverse effects of tyrosine kinase inhibitors, hypothyroidism appears to have a bright side.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/November-2017/Creo_Ana_MINN_web.jpg)
Pediatric thyroid nodules: Experienced radiologists best ultrasound risk stratification
- Author:
- Susan London
Experience is more predictive than ultrasound in evaluating pediatric thyroid nodules.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/October-2017/Smallridge_Robert_FL_web.jpg)
Generic, brand-name levothyroxine have similar cardiovascular outcomes
- Author:
- Susan London
VICTORIA, B.C. – Monthly medication costs for the brand-name drug were more than twice that of the generic drug.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/October-2017/128688_Villavicencio_Raquel_web.jpg)
Hypothyroidism carries higher surgical risk not captured by calculator
- Author:
- Susan London
VICTORIA, B.C. – Hypothyroid lengthens recovery surgery beyond time predicted by surgical risk calculator.